UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in Plexus Corp. (NASDAQ:PLXS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 70,506 shares of the technology company's stock after purchasing an additional 10,717 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.26% of Plexus worth $11,033,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. American Century Companies Inc. increased its holdings in Plexus by 72.2% in the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock worth $85,128,000 after buying an additional 228,027 shares in the last quarter. Nuveen Asset Management LLC boosted its holdings in shares of Plexus by 6.6% during the 4th quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock valued at $55,012,000 after acquiring an additional 21,911 shares during the last quarter. Northern Trust Corp grew its stake in shares of Plexus by 10.0% in the fourth quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock worth $51,967,000 after acquiring an additional 30,163 shares during the period. JPMorgan Chase & Co. grew its position in Plexus by 146.9% in the 4th quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock worth $40,501,000 after purchasing an additional 154,003 shares during the period. Finally, Fuller & Thaler Asset Management Inc. purchased a new stake in Plexus during the 4th quarter valued at $24,747,000. Institutional investors own 94.45% of the company's stock.

Plexus Stock Performance

Plexus stock traded down $1.15 during midday trading on Wednesday, hitting $131.88. The stock had a trading volume of 81,286 shares, compared to its average volume of 168,806. Plexus Corp. has a 52-week low of $100.96 and a 52-week high of $172.89. The company has a market capitalization of $3.57 billion, a PE ratio of 30.60 and a beta of 0.80. The firm's fifty day moving average is $125.94 and its two-hundred day moving average is $140.88. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The firm had revenue of $980.17 million during the quarter, compared to analysts' expectations of $980.07 million. During the same period in the prior year, the company posted $0.94 earnings per share. The company's revenue for the quarter was up 1.4% compared to the same quarter last year. On average, research analysts forecast that Plexus Corp. will post 5.9 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Needham & Company LLC reissued a "buy" rating and issued a $162.00 price objective (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Stifel Nicolaus set a $145.00 price objective on shares of Plexus in a research report on Thursday, April 24th. Finally, Benchmark restated a "buy" rating and issued a $160.00 price objective on shares of Plexus in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, Plexus has an average rating of "Moderate Buy" and a consensus target price of $155.67.

Insider Buying and Selling at Plexus

In other news, CEO Todd P. Kelsey sold 1,000 shares of the company's stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $130.00, for a total value of $130,000.00. Following the completion of the transaction, the chief executive officer now owns 78,714 shares of the company's stock, valued at $10,232,820. This represents a 1.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Patrick John Jermain sold 4,328 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $132.29, for a total value of $572,551.12. Following the sale, the chief financial officer now directly owns 25,637 shares in the company, valued at $3,391,518.73. This trade represents a 14.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 12,032 shares of company stock valued at $1,582,222 over the last ninety days. 1.76% of the stock is currently owned by company insiders.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.